Abstract
Medeze Group pcl, a stem cell banking company, will be listed on the Stock Exchange of Thailand with a market capitalization of THB 9.61 billion. The company offers stem cell banking services and plans to expand its business with newly raised capital.
MEDEZE Group PCL to be Listed on SET
The Stock Exchange of Thailand (SET) will list Medeze Group PCL, a pioneer in internationally-accredited stem cell banking technology, on October 15 under the symbol “MEDEZE”. The company has a market capitalization of THB 9.61 billion (approx. USD 290.60 million) at its initial public offering (IPO). SET Executive Vice President Amnouy Jiramahapoka announced that MEDEZE will be listed and start trading on SET in the Services Industry group within the Health Care Services sector.
MEDEZE’s Strategic Growth Plans
MEDEZE, with a paid-up capital of THB 534 million, offers stem cell analysis, isolation, culture, and banking solutions for newborns and adults. The company aims to expand its hair follicle cell banking business and upgrade its robotic cell culture capabilities with the newly raised funds. MEDEZE’s focus on innovative solutions and state-of-the-art technologies positions it as a trusted partner for both domestic and international clients, solidifying its reputation as a leading stem cell innovator in Thailand and ASEAN.
